The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2024

Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1745465

No of Pages : 91

Ask Your Query

Synopsis
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.

Global Pharmaceutical Grade Nicotinamide Mononucleotide market is projected to reach US$ 635.9 million in 2029, increasing from US$ 519.3 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmaceutical Grade Nicotinamide Mononucleotide market research.

Key manufacturers engaged in the Pharmaceutical Grade Nicotinamide Mononucleotide industry include GeneHarbor, Herbalmax, Shinkowa, EffePharm, Mirailab Bioscience, Bangtai Bio, Jindawei and Hongboyuan Life Technology, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

For production bases, global Pharmaceutical Grade Nicotinamide Mononucleotide production is dominated by and . The two regions contributed to % production share globally in 2022.

When refers to consumption region, % volume of Pharmaceutical Grade Nicotinamide Mononucleotide were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pharmaceutical Grade Nicotinamide Mononucleotide market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharmaceutical Grade Nicotinamide Mononucleotide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • GeneHarbor
  • Herbalmax
  • Shinkowa
  • EffePharm
  • Mirailab Bioscience
  • Bangtai Bio
  • Jindawei
  • Hongboyuan Life Technology

Segment by Type

  • Concentration≥98%
  • Concentration＜98%

Segment by Application

  • Health Products
  • Others

Production by Region

  • North America
  • Europe
  • China
  • Japan

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

The Pharmaceutical Grade Nicotinamide Mononucleotide report covers below items:

Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source

Index

1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Type
1.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Concentration≥98%
1.2.3 Concentration＜98%
1.3 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Application
1.3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Health Products
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Estimates and Forecasts (2018-2029)
1.4.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Manufacturers (2018-2023)
2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Pharmaceutical Grade Nicotinamide Mononucleotide, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Date of Enter into This Industry
2.9 Pharmaceutical Grade Nicotinamide Mononucleotide Market Competitive Situation and Trends
2.9.1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical Grade Nicotinamide Mononucleotide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical Grade Nicotinamide Mononucleotide Production by Region
3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region (2018-2029)
3.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Pharmaceutical Grade Nicotinamide Mononucleotide by Region (2024-2029)
3.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Region (2018-2029)
3.4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Pharmaceutical Grade Nicotinamide Mononucleotide by Region (2024-2029)
3.5 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Price Analysis by Region (2018-2023)
3.6 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2018-2029)
4 Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region
4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2018-2029)
4.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2018-2023)
4.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2018-2029)
5.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2018-2023)
5.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2024-2029)
5.1.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2018-2029)
5.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2018-2029)
5.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2018-2023)
5.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2024-2029)
5.2.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Type (2018-2029)
5.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Type (2018-2029)
6 Segment by Application
6.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2018-2029)
6.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2018-2023)
6.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2024-2029)
6.1.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2018-2029)
6.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2018-2029)
6.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2018-2023)
6.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2024-2029)
6.2.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Application (2018-2029)
6.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Application (2018-2029)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.1.2 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.1.3 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Herbalmax
7.2.1 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.2.2 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.2.3 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Herbalmax Main Business and Markets Served
7.2.5 Herbalmax Recent Developments/Updates
7.3 Shinkowa
7.3.1 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.3.2 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.3.3 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Shinkowa Main Business and Markets Served
7.3.5 Shinkowa Recent Developments/Updates
7.4 EffePharm
7.4.1 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.4.2 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.4.3 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.4.4 EffePharm Main Business and Markets Served
7.4.5 EffePharm Recent Developments/Updates
7.5 Mirailab Bioscience
7.5.1 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.5.2 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.5.3 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Mirailab Bioscience Main Business and Markets Served
7.5.5 Mirailab Bioscience Recent Developments/Updates
7.6 Bangtai Bio
7.6.1 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.6.2 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.6.3 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Bangtai Bio Main Business and Markets Served
7.6.5 Bangtai Bio Recent Developments/Updates
7.7 Jindawei
7.7.1 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.7.2 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.7.3 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Jindawei Main Business and Markets Served
7.7.5 Jindawei Recent Developments/Updates
7.8 Hongboyuan Life Technology
7.8.1 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Corporation Information
7.8.2 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio
7.8.3 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Hongboyuan Life Technology Main Business and Markets Served
7.7.5 Hongboyuan Life Technology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Chain Analysis
8.2 Pharmaceutical Grade Nicotinamide Mononucleotide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Grade Nicotinamide Mononucleotide Production Mode & Process
8.4 Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Marketing
8.4.1 Pharmaceutical Grade Nicotinamide Mononucleotide Sales Channels
8.4.2 Pharmaceutical Grade Nicotinamide Mononucleotide Distributors
8.5 Pharmaceutical Grade Nicotinamide Mononucleotide Customers
9 Pharmaceutical Grade Nicotinamide Mononucleotide Market Dynamics
9.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Trends
9.2 Pharmaceutical Grade Nicotinamide Mononucleotide Market Drivers
9.3 Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges
9.4 Pharmaceutical Grade Nicotinamide Mononucleotide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock